Geneform Technologies Limited

Active04549240 Private limited company
Incorporated
1 October 2002 (24 years)
Industry
Other research and experimental development on natural sciences and engineering (72190)
Directors
Jukka Laukkonen
Accounts type
Small
Region
South East
Address
61 London Road
Maidstone
ME16 8TX

Filing status

Accounts due
26 June 2027
Last accounts
26 September 2025
Conf. stmt due
15 October 2027
Last conf. stmt
1 October 2026

Officers 2 active

Officer details are public data from the Companies House register.

Laukkonen, Jukka
Director · Appointed 1 April 2021
Finnish
Born May 1969 (57)
Director · Appointed 7 December 2018
Finnish
Born October 1971 (55)
Officer history (12 former)
1 April 2021
Resigned Malinen, Pekka Juhani as Director
1 April 2021
Appointed Laukkonen, Jukka as Director
7 December 2018
Appointed Koivula, Antti Tapani as Director
6 December 2018
Resigned Tarkkanen, Kaisa as Director
30 April 2018
Appointed Malinen, Pekka Juhani as Director
30 April 2018
Resigned Kemppainen, Mikko Tapani as Director
2 November 2015
Resigned Seppanen, Marko Juhani Tapio as Director
1 October 2015
Appointed Tarkkanen, Kaisa as Director
1 October 2015
Resigned Rissanen, Jaakko Sakari as Director
8 August 2011
Appointed Kemppainen, Mikko Tapani as Director
8 August 2011
Appointed Seppanen, Marko Juhani Tapio as Director
1 August 2011
Appointed Rissanen, Jaakko Sakari as Director
1 August 2011
Resigned Somerfield Consultants Ltd as Corporate Secretary
1 August 2011
Resigned Hoser, Mark Jay, Dr as Director
1 August 2011
Resigned Karas, David Matthew as Director
15 October 2010
Resigned Sinclair, Michael Jeffrey, Dr as Director
14 September 2009
Appointed Sinclair, Michael Jeffrey, Dr as Director
7 September 2009
Appointed Karas, David Matthew as Director
18 August 2006
Appointed Somerfield Consultants Ltd as Corporate Secretary
31 December 2005
Resigned Anandappa, Francis Denzil Nihal as Secretary
7 October 2002
Resigned Brighton Secretary Ltd as Corporate Nominee Secretary
7 October 2002
Resigned Brighton Director Ltd as Corporate Nominee Director
1 October 2002
Appointed Brighton Secretary Ltd as Corporate Nominee Secretary
1 October 2002
Appointed Brighton Director Ltd as Corporate Nominee Director
1 October 2002
Appointed Anandappa, Francis Denzil Nihal as Secretary
1 October 2002
Appointed Hoser, Mark Jay, Dr as Director

Ownership 0 active

People and entities with significant control, from the Companies House PSC register

The company has declared that it has no person with significant control.
Former controllers (1)
26 March 2018
Ceased Orion Pharma UK Limited — Owns 75–100% of shares

Financials

Balance sheet as at 26 September 2025 · small accounts

Cash
£3,005

Trend

Shareholder Funds
(£1.0M) (£500k) £0 2022 2023 2024 2025 (£693,679) (£746,693) (£2,415) (£565)
Balance sheet detail
2025202420232022
Cash£3,005£3,600£4,474£1,321
Creditors (< 1 year)£6,015£751,167£5,600
Creditors (> 1 year)£0£689,400
Net Current Assets(£565)(£2,415)(£746,693)(£4,279)
Net Assets(£746,693)(£693,679)
Shareholder Funds(£565)(£2,415)(£746,693)(£693,679)

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
2 November 2026Confirmation statement with no updates1 October 2026

Some other companies at this address

Other companies in this industry

By trade and location

New companies in Maidstone →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?